Holen Sie sich die Stockscreener-App
5.80
0.86%
0.00
Schlusskurs vom Vortag:
$5.80
Offen:
$5.8
24-Stunden-Volumen:
66,582
Relative Volume:
0.34
Marktkapitalisierung:
$50.42M
Einnahmen:
$137.27M
Nettoeinkommen (Verlust:
$-123.57M
KGV:
-0.5265
EPS:
-11.016
Netto-Cashflow:
$-102.89M
1W Leistung:
-8.88%
1M Leistung:
-8.31%
6M Leistung:
-20.52%
1J Leistung:
-56.82%
1-Tages-Spanne:
$5.75
$6.00
1-Wochen-Bereich:
$5.75
$6.60
52-Wochen-Spanne:
$3.51
$14.24
Karyopharm Therapeutics Inc Stock (KPTI) Company Profile
Firmenname
Karyopharm Therapeutics Inc
Sektor
Branche
Telefon
617-658-0600
Adresse
85 WELLS AVENUE, NEWTON, MA
Vergleichen Sie KPTI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KPTI
Karyopharm Therapeutics Inc
|
5.815 | 92.38M | 137.27M | -123.57M | -102.89M | -11.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.25 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.03 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
829.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.66 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-07-16 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-07-11 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-01-19 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-09 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-11-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-08-06 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-08-06 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-07-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2020-01-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-07-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-07-05 | Bestätigt | H.C. Wainwright | Buy |
| 2019-07-05 | Bestätigt | Robert W. Baird | Outperform |
| 2019-03-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-02-28 | Bestätigt | BofA/Merrill | Underperform |
| 2019-02-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-12-03 | Eingeleitet | B. Riley FBR | Buy |
| 2018-11-09 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-05-24 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-04-02 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2016-09-08 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-30 | Hochstufung | Jefferies | Hold → Buy |
| 2016-08-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-28 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Karyopharm Therapeutics Inc Aktie (KPTI) Neueste Nachrichten
Karyopharm (KPTI) Surpasses Q3 Revenue Expectations with Clinica - GuruFocus
Karyopharm (KPTI) Projects Revenue Growth and Expense Reduction for FY25 - GuruFocus
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView
Karyopharm Therapeutics: Q3 Earnings Snapshot - WWLTV.com
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress - PR Newswire
Karyopharm Grows Revenue With Strong XPOVIO Sales And Partnerships - Finimize
Karyopharm Therapeutics Inc. stock trend outlook and recovery path2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Using Ichimoku Cloud for Karyopharm Therapeutics Inc. technicalsQuarterly Earnings Report & Free Fast Gain Swing Trade Alerts - newser.com
Is Karyopharm Therapeutics Inc. (25K0) stock cheap vs fundamentalsMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com
Will Karyopharm Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Drop Watch & Growth Focused Stock Reports - newser.com
Can Karyopharm Therapeutics Inc. stock continue upward trend2025 Market Sentiment & Daily Stock Trend Reports - newser.com
How geopolitical tensions affect Karyopharm Therapeutics Inc. stockWeekly Trend Summary & AI Driven Price Predictions - newser.com
What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investors2025 Technical Overview & Reliable Volume Spike Alerts - newser.com
Analyzing net buyer seller activity in Karyopharm Therapeutics Inc.July 2025 Closing Moves & Weekly Chart Analysis and Guides - newser.com
Is Karyopharm Therapeutics Inc. stock safe for conservative investorsPortfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risksWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Karyopharm Therapeutics Inc expected to post a loss of $3.13 a shareEarnings Preview - TradingView
Earnings To Watch: Karyopharm Therapeutics Inc (KPTI) Reports Q3 2025 Result - Yahoo Finance
Technical signs of recovery in Karyopharm Therapeutics Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com
Is Karyopharm Therapeutics Inc. (25K0) stock a top hedge fund pickJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Regression analysis insights on Karyopharm Therapeutics Inc. performance2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-31 05:27:00 - newser.com
Can Karyopharm Therapeutics Inc. (25K0) stock sustain revenue momentumQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
Karyopharm Therapeutics (KPTI) Price Target Decreased by 10.98% to 15.98 - MSN
Karyopharm Therapeutics (NASDAQ:KPTI) Shares Pass Above 50-Day Moving AverageHere's What Happened - MarketBeat
Is it time to cut losses on Karyopharm Therapeutics Inc.Trade Risk Summary & Low Drawdown Trading Strategies - newser.com
Is Karyopharm Therapeutics Inc. stock supported by strong fundamentals2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Will Karyopharm Therapeutics Inc. outperform the market2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Will Karyopharm Therapeutics Inc. stock gain from strong economyWall Street Watch & Intraday High Probability Alerts - newser.com
Karyopharm Therapeutics (KPTI) Projected to Post Earnings on Tuesday - MarketBeat
Finanzdaten der Karyopharm Therapeutics Inc-Aktie (KPTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):